There are 4 papers on familial chylomicronemia syndrome in aging research: none in people yet, 4 reviews.
4 papers study it2 more mention it2 findings
1 new paper in 30 daysSee all 6 papers on familial chylomicronemia syndrome
Associations
2Acute pancreatitis
upin humans1
1 study
Acute pancreatitis
upin humans1
Familial chylomicronemia syndrome raises the risk of acute pancreatitis in humans (plasma triglycerides >10 mmol/L) (plasma triglycerides >10 mmol/L; high risk).
“Patients with FCS exhibit markedly elevated plasma triglyceride levels (>10mmol/L) and are at high risk for acute pancreatitis.”
Reviewplasma triglycerides >10 mmol/L
Annales d'endocrinologie
LPL
upin humans1
1 study
LPL
upin humans1
LPL is associated with familial chylomicronemia syndrome in humans (mutations in lipoprotein lipase or its cofactors).
“Familial chylomicronemia syndrome (FCS) is a major form of genetic hypertriglyceridemia caused by mutations in genes encoding lipoprotein lipase or one of its cofactors”
Reviewmutations in lipoprotein lipase or its cofactors
Annales d'endocrinologie
Trial sponsors
Company4 trialsPhase 3162 people
Company1 trialPhase 337 people
Latest
5 papers in 12 monthsCurrent Atherosclerosis Reports
Targeting Apolipoprotein C-III in Hypertriglyceridemia: Implications for Pancreatitis and Cardiovascular risk
Journal of Cardiovascular Pharmacology
Silencing Triglycerides: The Clinical Impact of Plozasiran and apoC-III Inhibition in Severe Hypertriglyceridemia
Current Opinion in Endocrinology, Diabetes, and Obesity
Hypertriglyceridemia: updates from clinical trials of new agents and real-world registries
ReviewHypertriglyceridemia
Atherosclerosis
Drug target Mendelian randomization supports apolipoprotein C3-lowering for lipoprotein-lipid levels reductions and cardiovascular diseases prevention
Mendelian randomization in 35,378 peopleMechanisms